Nuveen, LLC Bristol Myers Squibb CO Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nuveen, LLC holds 10,237,229 shares of BMY stock, worth $493 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
10,237,229Holding current value
$493 Million% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,796Shares Held
1.61BCall Options Held
27.4MPut Options Held
28.1M-
Vanguard Group Inc Valley Forge, PA191MShares$9.22 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.21 Billion0.52% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.58 Billion0.22% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.2 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...